Glenmark Pharma has managed to receive the final nod from the US Health Regulator’s for it’s latest drug Amphetamine Sulfate tablets for central nervous system. The tablets are a generic version of Evekeo tablets of Arbor Pharmaceuticals LLC.
The Amphetamine Sulfate tablets USP will be available in the strengths of 5 mg and 10 mg. After the announcement Glenmark Pharma shares were trading at Rs. 478.50 per share on BSE Index.